JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
Read original at benzingaStocks · News reference
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 4, 2026, 12:14 PM
- Checked
- Aug 4, 2026, 12:14 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.
Read original at benzingaOppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
Read original at benzingaTruist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
Read original at benzinga